FAP and adenocarcinoma: Contrary to Liao et al., they found no significant difference in overall survival between the high and low FAP-expression groups in the overall cohort (p = 0.07) or the adenocarcinoma subgroup (p = 0.986), and even a positive effect of high FAP expression on overall survival in the SCC subgroup (p = 0.043) [24].